Clinical trial

TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients

NCT06455917

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-01-22

PhasePHASE2

Study timeline

Study start (actual)2025-01-22Date precision: day

Registry last updated2025-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Lung Cancer (NSCLC)unresolved

Interventions

TILs（Tumor Infiltrating Lymphocytes）DRUG

Sponsors & collaborators

University Hospital, Basel, Switzerlandlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06455917 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.